Abstract:BackgroundParkinson's disease (PD) is characterized by dopaminergic neuronal loss in the substantia nigra pars compacta and intracellular inclusions called Lewy bodies (LB). During the course of disease, misfolded α-synuclein, the major constituent of LB, spreads to different regions of the brain in a prion-like fashion, giving rise to successive non-motor and motor symptoms. Etiology is likely multifactorial, and involves interplay among aging, genetic susceptibility and environmental factors.Main bodyThe prevalence of PD rises exponentially with age, and aging is associated with impairment of cellular pathways which increases susceptibility of dopaminergic neurons to cell death. However, the majority of those over the age of 80 do not have PD, thus other factors in addition to aging are needed to cause disease. Discovery of neurotoxins which can result in parkinsonism led to efforts in identifying environmental factors which may influence PD risk. Nevertheless, the causality of most environmental factors is not conclusively established, and alternative explanations such as reverse causality and recall bias cannot be excluded. The lack of geographic clusters and conjugal cases also go against environmental toxins as a major cause of PD. Rare mutations as well as common variants in genes such as SNCA, LRRK2 and GBA are associated with risk of PD, but Mendelian causes collectively only account for 5% of PD and common polymorphisms are associated with small increase in PD risk. Heritability of PD has been estimated to be around 30%. Thus, aging, genetics and environmental factors each alone is rarely sufficient to cause PD for most patients.ConclusionPD is a multifactorial disorder involving interplay of aging, genetics and environmental factors. This has implications on the development of appropriate animal models of PD which take all these factors into account. Common converging pathways likely include mitochondrial dysfunction, impaired autophagy, oxidative stress and neuroinflammation, which are associated with the accumulation and spread of misfolded α-synuclein and neurodegeneration. Understanding the mechanisms involved in the initiation and progression of PD may lead to potential therapeutic targets to prevent PD or modify its course.

Defective Autophagy in Parkinson’s Disease: Lessons from Genetics

Virulence genes of Parkinson's disease and autophagy

Decoding the Role of Familial Parkinson’s Disease-Related Genes in DNA Damage and Repair

Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease

Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease

Crosstalk Between Presynaptic Trafficking and Autophagy in Parkinson's Disease

The Cross-Links of Endoplasmic Reticulum Stress, Autophagy, and Neurodegeneration in Parkinson's Disease

The Cross-Links of Endoplasmic Reticulum Stress, Autophagy, and Neurodegeneration in Parkinson’s Disease

Deconvoluting the complexity of autophagy and Parkinson's disease for potential therapeutic purpose

Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches

Key genes and convergent pathogenic mechanisms in Parkinson disease

Parkin, PINK1, DJ-1 and Mitochondria Dysfunctionwith Parkinson’s Disease

Mitophagy in Parkinson’s Disease: From Pathogenesis to Treatment

The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease

Mechanisms of PINK1, ubiquitin and Parkin interactions in mitochondrial quality control and beyond

Dysregulation of autophagy and mitochondrial function in Parkinson's disease.

Gene–environment Interactions: Key to Unraveling the Mystery of Parkinson's Disease

Mitophagy, a Form of Selective Autophagy, Plays an Essential Role in Mitochondrial Dynamics of Parkinson’s Disease

Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson's Disease

Cell biology of Parkinson's disease: Mechanisms of synaptic, lysosomal, and mitochondrial dysfunction

Chaperone-Mediated Autophagy and Mitochondrial Homeostasis in Parkinson’s Disease